One-year outcomes after treatment with a drug-coated balloon catheter system for lower urinary tract symptoms related to benign prostatic hyperplasia.

Steven A KaplanMerycarla PichardoEdwin RijoGustavo EspinoRamon Rodriguez LayRafael Estrella

Published in: Prostate cancer and prostatic diseases (2021)

Treatment with the minimally invasive Optilume BPH Catheter System is safe and showed subjective and objective improvements in LUTS. Benefits were rapid and persisted through 1 year. The initial results warrant further evaluation of this therapy as a treatment option for patients with LUTS related to BPH.

Keyphrases

lower urinary tract symptoms
benign prostatic hyperplasia
minimally invasive
emergency department
ultrasound guided
depressive symptoms
physical activity
drug induced
adverse drug